Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate

References

• Brownstein MJ, Palkovits M, Saavedra JM, Bassiri RM, Utiger RD. Thyrotropin-releasing hormone in specific nuclei of rat brain. Science 1974, 185, 267–269.
   Google Scholar
• Oliver C, Eskay RL, Ben-Jonathan N, Porter JC. Distribution and concentration of TRH in the rat brain. Endocrinology 1974, 95, 540–546.
   Google Scholar
• Griffiths EC. Thyrotrophin releasing hormone: endocrine and central effects. Psychoneuroendocrinology 1985, 10, 225–235.
   PubMed Web of Science ®Google Scholar
• Horita A, Carino MA, Lai H. Pharmacology of thyrotropin-releasing hormone. Annu Rev Pharmacol Toxicol 1986, 26, 311–332.
   PubMedGoogle Scholar
• Mizobe T, Okuda C. Changes in brain thyrotropin-releasing hormone in reversible and irreversible hemorrhagic shock in the rat. Circ Shock 1988, 26, 245–256.
   Google Scholar
• Okuda C, Mizobe T, Miyazaki M. Involvement of endogenous thyrotropin-releasing hormone in central regulation of the cardiovascular system after bleeding in conscious rats. Brain Res 1988, 474, 399–402.
   Google Scholar
• Okuda C, Sawa T, Harada M, Miyazaki M. Hemorrhage-induced regional brain thyrotropin-releasing hormone release in conscious rats measured by microdialysis. Life Sci 1990, 47, 1997–2002.
   Google Scholar
• Guarini S, Gherardi S, Calabrò G, Bertolini A. A pharmacological study of the cardiovascular effects of TRH-T in haemorrhagic shock in rats. Arch Int Pharmacodyn Ther 1989, 299, 65–76.
   Google Scholar
• Tagliavini S, Bertolini E, Bazzani C, Bertolini A, Guarini S. Influence of TRH on regional blood flow and metabolic acidosis in a model of volume-controlled hemorrhagic shock in rats. Neuropeptides 1991, 20, 233–238.
   Google Scholar
• Coppi G, Falcone A. The thyrotropin releasing hormone analogue, RGH 2202, reverses experimental haemorrhagic shock in rats. Eur J Pharmacol 1990, 182, 185–188.
   Google Scholar
• Bassiri RM, Utiger RD. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans. J Clin Invest 1973, 52, 1616–1619.
   PubMed Web of Science ®Google Scholar
• Hirayama K, Tashiro K, Takayanagi T, Takahashi K, Ogawa N, Arai K. The clinical evaluation of TA-0910 in spinocerebellar degeneration (SCD): A double blind cross-over comparative study vs. placebo. J Clin Therap Med 1997, 13, 4133–4167.
   Google Scholar
• Kanazawa I, Satoyoshi E, Hirayama K, Takayanagi T, Takahashi K, Kowa H, Tashiro K, Osame M, Shimizu N, Kachi T, Nakashima M. Clinical evaluation of taltirelin hydrate (TA-0910) in patients with spinocerebellar degeneration: A multi-center double-blind comparative study with placebo. J Clin Therap Med 1997, 13, 4169–4224.
   Google Scholar
• Suzuki M, Sugano H, Matsumoto K, Yamamura M, Ishida R. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. J Med Chem 1990, 33, 2130–2137.
   Google Scholar
• Yamamura M, Kinoshita K, Nakagawa H, Tanaka T, Maeda K, Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration. Jpn J Pharmacol 1990, 53, 451–461.
   Google Scholar
• Yamamura M, Kinoshita K, Nakagawa H, Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (II): Involvement of the DA system in the locomotor stimulating action of TA-0910. Jpn J Pharmacol 1991, 55, 57–68.
   PubMedGoogle Scholar
• Yamamura M, Kinoshita K, Nakagawa H, Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (III): Inhibition of pentobarbital anesthesia. Jpn J Pharmacol 1991, 55, 69–80.
   Google Scholar
• Kinoshita K, Nagao T, Ono H. Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats. Neuropharmacology 1994, 33, 1183–1188.
   Google Scholar
• Kinoshita K, Fujitsuka T, Yamamura M, Matsuoka Y. Effects of TA-0910, a novel orally active thyrotropin-releasing hormone analog, on the gait of ataxic animals. Eur J Pharmacol 1995, 274, 65–72.
   Google Scholar
• Kinoshita K, Kawashima K, Kawashima Y, Fukuchi I, Yamamura M, Matsuoka Y. Effect of TA-0910, a novel thyrotropin-releasing hormone analog, on in vivo acetylcholine release and turnover in rat brain. Jpn J Pharmacol 1996, 71, 139–145.
   Google Scholar
• Kodama H, Fukushima T, Chishima S, Sugihara J, Yoshikawa M. Disposition of taltirelin (3): The transfer into the brain and brain distribution in rats. Xenobio Metabol Dispos 1997, 12, 483–490.
   Google Scholar
• Gupta RK, Babbar R, Fahim M. Effect of ionophore monensin on anaesthetized dogs in hemorrhagic hypotension. Vascul Pharmacol 2005, 42, 69–75.
   Google Scholar
• Asai H, Kinoshita K, Yamamura M, Matsuoka Y. Diversity of thyrotropin-releasing hormone receptors in the pituitary and discrete brain regions of rats. Jpn J Pharmacol 1999, 79, 313–317.
   PubMedGoogle Scholar
• Asai H, Asahi T, Yamamura M, Yamauchi-Kohno R, Saito A. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats. Pharmacol Biochem Behav 2005, 82, 646–651.
   Google Scholar
• Dulchavsky SA, Lucas CE, Ledgerwood AM, Grabow D, Brown TR, Bagchi N. Triiodothyronine (T3) improves cardiovascular function during hemorrhagic shock. Circ Shock 1993, 39, 68–73.
   PubMedGoogle Scholar
• Shigematsu H, Smith RA, Shatney CH. Triiodothyronine increases survival in canine hemorrhagic shock. Resuscitation 1987, 15, 233–243.
   PubMed Web of Science ®Google Scholar
• Moriyasu M, Nasu M, Honda H, Sakamoto T, Yamamura M, Matsuoka Y. Effect of (-)-N-[(S)-hexahydro-l-methyl-2, 6-dioxo-4-pyrimidinylcarbonyl]-L-histidyl-L-prolinamide (TA-0910), a new TRH analog, on plasma levels of TSH and thyroid hormones in rats. Nippon Yakurigaku Zasshi 1996, 107, 285–297.
   Google Scholar
• Brezenoff HE, Giuliano R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu Rev Pharmacol Toxicol 1982, 22, 341–381.
   PubMed Web of Science ®Google Scholar
• Haxhiu MA, Mitra J, van Lunteren E, Bruce EN, Cherniack NS. Hypoglossal and phrenic responses to cholinergic agents applied to ventral medullary surface. Am J Physiol 1984, 247, R939–R944.
   PubMed Web of Science ®Google Scholar
• Kubo T. Cholinergic mechanism and blood pressure regulation in the central nervous system. Brain Res Bull 1998, 46, 475–481.
   Google Scholar
• Kubo T, Hagiwara Y, Sekiya D, Fukumori R. Evidence for involvement of the lateral parabrachial nucleus in mediation of cholinergic inputs to neurons in the rostral ventrolateral medulla of the rat. Brain Res 1998, 789, 23–31.
   Google Scholar
• Kubo T, Hagiwara Y, Sekiya D, Fukumori R. Midbrain central gray is involved in mediation of cholinergic inputs to the rostral ventrolateral medulla of the rat. Brain Res Bull 1999, 50, 41–46.
   Google Scholar
• Kubo T, Hagiwara Y, Sekiya D, Chiba S, Fukumori R. Cholinergic inputs to rostral ventrolateral medulla pressor neurons from hypothalamus. Brain Res Bull 2000, 53, 275–282.
   Google Scholar
• Mallios VJ, Lydic R, Baghdoyan HA. Muscarinic receptor subtypes are differentially distributed across brain stem respiratory nuclei. Am J Physiol 1995, 268, L941–L949.
   Google Scholar
• Guarini S, Tagliavini S, Ferrari W, Bertolini A. Reversal of haemorrhagic shock in rats by cholinomimetic drugs. Br J Pharmacol 1989, 98, 218–224.
   PubMed Web of Science ®Google Scholar
• Liu LM, Hu DY, Chen HS, Lu RQ, Yan W. The importance of delta and kappa opioid receptors in the property of thyrotropin-releasing hormone against hemorrhagic shock. Shock 1997, 7, 60–64.
   Google Scholar
• Nattie EE, Li AH. Ventral medulla sites of muscarinic receptor subtypes involved in cardiorespiratory control. J Appl Physiol 1990, 69, 33–41.
   Google Scholar
• Sirén AL, Powell E, Feuerstein G. Thyrotropin releasing hormone in hypovolemia: a hemodynamic evaluation in the rat. Am J Physiol 1986, 250, H1093–H1101.
   Google Scholar
• Yamamura M, Kinoshita K, Nakagawa H, Ishida R. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats. Jpn J Pharmacol 1991, 55, 241–253.
   Google Scholar
• Urayama A, Yamada S, Kimura R, Zhang J, Watanabe Y. Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice. Life Sci 2002, 72, 601–607.
   PubMed Web of Science ®Google Scholar
• Holaday JW, Faden AI. Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock. Regul Pept 1983, 7, 111–125.
   Google Scholar
• Amir S, Harel M, Schachar A. Thyrotropin-releasing hormone (TRH) improves survival in anaphylactic shock: a central effect mediated by the sympatho-adrenomedullary beta-adrenoceptive system. Brain Res 1984, 298, 219–224.
   Google Scholar
• Faden AI, Jacobs TP, Holaday JW. Thyrotropin-releasing hormone improves neurologic recovery after spinal trauma in cats. N Engl J Med 1981, 305, 1063–1067.
   PubMed Web of Science ®Google Scholar